ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses

May 31, 2013

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

NCI Adds $25 Million to R01, P01 Grant Pool In Fiscal 1990

February 23, 1990

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999

In Brief: Groups agree On Mammography Screening: Money Bill Markups Due After July 4 Recess

June 23, 1989

DCCP Board Approves Concept Of RFA, New, Competing Contracts

October 15, 1982